𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CaSki )

✍ Scribed by Olivier Pradier; Margret Rave-Fränk; Jörg Lehmann; Eva Lücke; Oliver Boghun; Clemens-F. Hess; Heinz Schmidberger

Publisher
John Wiley and Sons
Year
2001
Tongue
French
Weight
124 KB
Volume
91
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Modulation of galectin-1 content in huma
Modulation of galectin-1 content in human head and neck squamous carcinoma cells by sodium butyrate
✍ Ann Gillenwater; Xiao-Chun Xu; Yuval Estrov; Peter G. Sacks; Dafna Lotan; Reuben 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 397 KB 👁 2 views

Galectin-1 and galectin-3 are ␤-galactoside-binding proteins thought to be important for cellular interactions, growth regulation and differentiation. Alterations in cellular content of galectins have been associated with differentiation, transformation and malignant progression. We examined the mod

Effects of sodium butyrate on growth, di
Effects of sodium butyrate on growth, differentiation, and apoptosis in head and neck squamous carcinoma cell lines
✍ Ann Gillenwater; Chang-Ping Zou; Meiling Zhong; Reuben Lotan 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB 👁 2 views

Background. Biologic agents that reverse early changes in the aerodigestive tract mucosa have potential treatment applications for patients with field cancerization of the upper aerodigestive tract. Sodium butyrate (BA) is a normal dietary constituent that induces differentiation and inhibits growth

Bioreductive alkylating agent porfiromyc
Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck
✍ Bruce G. Haffty; Yung H. Son; Lynn D. Wilson; Rose Papac; Diana Fischer; Sara Ro 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Porfiromycin (methyl mitomycin C) has been shown in laboratory studies to have increased preferential cytotoxicity to hypoxic cells and therefore may provide enhanced therapeutic efficacy over mitomycin C when used in combination with radiation therapy (RT). The purpose of the two clinical studies r